1. Home
  2. PCF vs BHST Comparison

PCF vs BHST Comparison

Compare PCF & BHST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo High Income Securities Fund

PCF

High Income Securities Fund

HOLD

Current Price

$5.63

Market Cap

106.5M

Sector

Finance

ML Signal

HOLD

Logo BioHarvest Sciences Inc.

BHST

BioHarvest Sciences Inc.

HOLD

Current Price

$3.94

Market Cap

97.7M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
PCF
BHST
Founded
N/A
2007
Country
United States
Canada
Employees
N/A
87
Industry
Trusts Except Educational Religious and Charitable
Sector
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
106.5M
97.7M
IPO Year
1994
N/A

Fundamental Metrics

Financial Performance
Metric
PCF
BHST
Price
$5.63
$3.94
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$10.00
AVG Volume (30 Days)
54.3K
34.2K
Earning Date
01-01-0001
05-15-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$146.27
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$5.36
$3.57
52 Week High
$6.51
$12.80

Technical Indicators

Market Signals
Indicator
PCF
BHST
Relative Strength Index (RSI) 49.08 43.74
Support Level $5.39 N/A
Resistance Level $5.73 $4.54
Average True Range (ATR) 0.08 0.20
MACD -0.00 -0.03
Stochastic Oscillator 47.37 53.63

Price Performance

Historical Comparison
PCF
BHST

About PCF High Income Securities Fund

High Income Securities Fund is a closed-end management investment company. Its primary objective is to provide high current income and capital appreciation is the secondary objective. The Fund pursues its objective mainly by investing in both convertible bonds and convertible preferred stocks. The Fund also invests significantly in high-yielding non-convertible securities with the potential for capital appreciation.

About BHST BioHarvest Sciences Inc.

BioHarvest Sciences Inc is the developer and owner of the patented bio-cell growth platform farming technology. This company is the industrial large-scale plant cell growth technology capable of directly and constantly producing active plant ingredients without the necessity to grow the plant itself. The company is focused on leveraging its botanical synthesis technology to develop the next generation of science-based and clinical therapeutic solutions, within two business verticals - nutraceutical health and wellness products such as dietary supplements, and the development of plant cell-based Active Pharmaceutical Ingredients (APIs) that focus on specific medical indications.

Share on Social Networks: